MedBright AI Issues Clarifying News Release on Continuous Disclosure Record
VANCOUVER, British Columbia, Aug. 08, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) announces that as a result of a review by the British Columbia Securities Commission, the Company is issuing the following news release to clarify the Company’s disclosure.
Related news for (MBAIF)
- MedBright AI Announces the Appointment of Christopher Heath as CEO and Termination of Letter of Intent
- MedBright AI Announces Strategic Acquisition by Numinus Wellness
- Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform
- Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations